Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment

BACKGROUND: Diabetes mellitus is a chronic multisystem disease with a high global prevalence, including in Saudi Arabia. The Glucagon-like Peptide (GLP-1) receptor agonist liraglutide is known to lower glucose levels, reduce weight and improve cardiovascular outcome. However, mechanisms underlying t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekhzaimy, Aishah A, Masood, Afshan, Benabdelkamel, Hicham, Elhassan, Tasnem, Musambil, Mohthash, Alfadda, Assim A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152203/
https://www.ncbi.nlm.nih.gov/pubmed/35616478
http://dx.doi.org/10.1177/14791641221094322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152203/
https://www.ncbi.nlm.nih.gov/pubmed/35616478
http://dx.doi.org/10.1177/14791641221094322

Ejemplares similares